Details for New Drug Application (NDA): 018470
✉ Email this page to a colleague
The generic ingredient in CIBACALCIN is calcitonin human. There are fourteen drug master file entries for this compound. Additional details are available on the calcitonin human profile page.
Summary for 018470
Tradename: | CIBACALCIN |
Applicant: | Novartis |
Ingredient: | calcitonin human |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.5MG/VIAL | ||||
Approval Date: | Oct 31, 1986 | TE: | RLD: | No |
Expired US Patents for NDA 018470
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | CIBACALCIN | calcitonin human | INJECTABLE;INJECTION | 018470-001 | Oct 31, 1986 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | CIBACALCIN | calcitonin human | INJECTABLE;INJECTION | 018470-001 | Oct 31, 1986 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription